[1]
H, A. et al. 2023. A SINGLE-CENTRE EXPERIENCE IN UTILIZATION OF MITOTANE AS AN ADJUVANT THERAPY FOR ADRENOCORTICAL CARCINOMA. Journal of the ASEAN Federation of Endocrine Societies. 38, S2 (Jul. 2023), 8. DOI:https://doi.org/10.15605/jafes.038.S2.08.